Purple Biotech Reaches Recommended Phase 2 Dose for NT219
Go back to Purple Biotech Reaches Recommended Phase 2 Dose for NT219| (NASDAQ: PPBT) | Delayed: 1.77 +0.07 (4.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.70 | 52 Week High | $ | |||
| Open | $1.80 | 52 Week Low | $ | |||
| Day High | $1.80 | P/E | N/A | |||
| Day Low | $1.70 | EPS | $ | |||
| Volume | 39,512 | |||||
| (NASDAQ: PPBT) | Delayed: 1.77 +0.07 (4.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.70 | 52 Week High | $ | |||
| Open | $1.80 | 52 Week Low | $ | |||
| Day High | $1.80 | P/E | N/A | |||
| Day Low | $1.70 | EPS | $ | |||
| Volume | 39,512 | |||||

